CN Patent

CN102293734A — 托伐普坦固体分散体及其制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2011-12-28 · 14y expired

What this patent protects

本发明涉及托伐普坦固体分散体及其制备方法，特别是一种包含托伐普坦和载体交联聚乙烯吡咯烷酮的固体分散体，该固体分散体优选进一步加入水溶性聚合物，所述固体分散体具有更好的热力学稳定性和溶解性，包含本发明固体分散体的药物组合物可以提高释放速率和生物利用度。

USPTO Abstract

本发明涉及托伐普坦固体分散体及其制备方法，特别是一种包含托伐普坦和载体交联聚乙烯吡咯烷酮的固体分散体，该固体分散体优选进一步加入水溶性聚合物，所述固体分散体具有更好的热力学稳定性和溶解性，包含本发明固体分散体的药物组合物可以提高释放速率和生物利用度。

Drugs covered by this patent

Patent Metadata

Patent number
CN102293734A
Jurisdiction
CN
Classification
—
Expires
2011-12-28
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.